Stocks
USANA Health Sciences (USNA) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 16.3% | 10.9% | 13.0% | 10.1% | 12.3% | 10.2% | ||
| Changes by years, y/y, % | +2pp | -5pp | +2pp | -3pp | +2pp | -4.9% | |||
USANA Health Sciences. EBITDA margin, %
USANA Health Sciences. EBITDA margin, changes, pp
USANA Health Sciences (USNA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 14.2% | 8.38% | 11.1% | 9.32% | 12.1% | 10.2% | |
| Changes by years, y/y, % | +3pp | -2pp | +1pp | -3pp | +0pp | |||
| Changes by quarters, q/q, % | +2pp | -6pp | +3pp | -2pp | +3pp | |||
